Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA
Ophthalmol Retina
.
2024 Oct 16:S2468-6530(24)00478-0.
doi: 10.1016/j.oret.2024.10.007.
Online ahead of print.
Authors
Charles C Wykoff
1
,
Diana V Do
2
,
W Lloyd Clark
3
,
David S Boyer
4
,
Dilsher S Dhoot
5
,
Dennis M Marcus
6
,
Robert Vitti
7
,
Alyson J Berliner
7
,
Kimberly Reed
7
,
Yenchieh Cheng
7
,
Hadi Moini
7
,
David M Brown
8
Affiliations
1
Retina Consultants of Texas, Houston, Texas. Electronic address: charleswykoff@gmail.com.
2
Byers Eye Institute, Stanford University, Palo Alto, California.
3
Palmetto Retina Center, West Columbia, South Carolina.
4
Retina-Vitreous Associates Medical Group, Los Angeles, California.
5
California Retina Consultants/Retina Consultants of America, Santa Barbara, California.
6
Southeast Retina Center, Augusta, Georgia.
7
Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
8
Retina Consultants of Texas, Houston, Texas.
PMID:
39424059
DOI:
10.1016/j.oret.2024.10.007
No abstract available
Keywords:
Aflibercept; Anti-VEGF; Diabetic Retinopathy Severity Scale; Diabetic retinopathy.